MENU
+Compare
ELAB
Stock ticker: NASDAQ
AS OF
Jun 6 closing price
Price
$2.17
Change
+$0.02 (+0.93%)
Capitalization
2.98M

ELAB PMGC Holdings Inc Forecast, Technical & Fundamental Analysis

PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation... Show more

ELAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ELAB with price predictions
Jun 06, 2025

ELAB's RSI Oscillator ascends from oversold territory

The RSI Oscillator for ELAB moved out of oversold territory on June 02, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 24 similar instances when the indicator left oversold territory. In of the 24 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 16 cases where ELAB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ELAB advanced for three days, in of 56 cases, the price rose further within the following month. The odds of a continued upward trend are .

ELAB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on May 23, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ELAB as a result. In of 27 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELAB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ELAB entered a downward trend on June 06, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.367) is normal, around the industry mean (16.648). P/E Ratio (0.000) is within average values for comparable stocks, (59.923). ELAB's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.234). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.067) is also within normal values, averaging (260.036).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ELAB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ELAB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ELAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
120 Newport Center Drive
Phone
+1 866 794-4940
Employees
18
Web
https://www.elevailabs.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGFRX13.98N/A
N/A
Nationwide BNY Mellon Dyn US Core R
IVGSX22.80N/A
N/A
VY® Invesco Growth and Income S
GHAYX41.05N/A
N/A
VanEck Global Resources Fund Y
FIQWX17.15N/A
N/A
Fidelity Advisor Strategic Div & Inc Z
MSHOX13.75N/A
N/A
Morgan Stanley Inst Permanence C

ELAB and Stocks

Correlation & Price change

A.I.dvisor tells us that ELAB and EPIX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ELAB and EPIX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAB
1D Price
Change %
ELAB100%
+0.93%
EPIX - ELAB
30%
Poorly correlated
N/A
LXRX - ELAB
25%
Poorly correlated
+6.93%
EDSA - ELAB
22%
Poorly correlated
-6.63%
REGN - ELAB
20%
Poorly correlated
+2.10%
PRAX - ELAB
20%
Poorly correlated
+5.44%
More